Regulation of dendrite morphology and excitatory synapse formation by zDHHC15.


Journal

Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457

Informations de publication

Date de publication:
05 07 2019
Historique:
received: 23 01 2019
accepted: 28 05 2019
pubmed: 14 6 2019
medline: 14 7 2020
entrez: 14 6 2019
Statut: epublish

Résumé

Protein palmitoylation is the most common post-translational lipid modification in the brain and is mediated by a family of 24 zDHHC enzymes. There has been growing interest in zDHHCs due to mounting evidence that these enzymes play key roles in the development and function of neuronal connections, and the fact that a number of zDHHCs have been associated with neurodevelopmental and neurodegenerative diseases. Loss-of-function variants in several zDHHCs, including zDHHC15, have been identified in patients with intellectual disabilities; however, the function of zDHHC15 in the brain has not been well studied. Here, we demonstrate that knocking down zDHHC15 in primary rat hippocampal cultures reduces dendritic outgrowth and arborization, as well as spine maturation. Moreover, knockdown of zDHHC15 reduces palmitoylation of PSD-95 and its trafficking into dendrites, resulting in an overall decrease in the density of excitatory synapses being formed onto mutant cells.

Identifiants

pubmed: 31189538
pii: jcs.230052
doi: 10.1242/jcs.230052
pmc: PMC6633394
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0
Disks Large Homolog 4 Protein 0
Acyltransferases EC 2.3.-
Zdhhc15 protein, rat EC 2.3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : MOP-142721
Pays : Canada
Organisme : CIHR
ID : PJT-148938
Pays : Canada

Informations de copyright

© 2019. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

J Cell Biol. 2000 Jan 10;148(1):159-72
pubmed: 10629226
Hippocampus. 2000;10(5):617-25
pubmed: 11075833
J Biol Chem. 2001 Nov 30;276(48):44984-92
pubmed: 11546762
Nat Genet. 2003 Mar;33(3):401-6
pubmed: 12590264
Cytometry A. 2004 Apr;58(2):167-76
pubmed: 15057970
Neuron. 2004 Dec 16;44(6):987-96
pubmed: 15603741
Eur J Hum Genet. 2005 Aug;13(8):970-7
pubmed: 15915161
Biochim Biophys Acta. 2006 Apr;1761(4):474-83
pubmed: 16647879
J Neurosci. 2006 Dec 6;26(49):12758-68
pubmed: 17151279
Nat Protoc. 2006;1(4):2152-61
pubmed: 17487207
Mol Biol Cell. 2008 Aug;19(8):3415-25
pubmed: 18508921
J Biol Chem. 2008 Sep 5;283(36):25014-26
pubmed: 18596047
Mol Cell Biol. 2009 Jan;29(2):435-47
pubmed: 19001095
J Biol Chem. 2009 Feb 6;284(6):3793-803
pubmed: 19074428
Mol Membr Biol. 2009 Jan;26(1):55-66
pubmed: 19085289
J Cell Biol. 2009 Jul 13;186(1):147-60
pubmed: 19596852
PLoS Genet. 2009 Nov;5(11):e1000748
pubmed: 19956733
Nat Rev Neurosci. 2010 Mar;11(3):161-75
pubmed: 20168314
Cell. 2010 Apr 30;141(3):458-71
pubmed: 20416930
J Biol Chem. 2010 Aug 6;285(32):24629-38
pubmed: 20519516
Mol Biol Cell. 2011 Jun 1;22(11):1930-42
pubmed: 21471001
Mol Biol Cell. 2011 Jun 1;22(11):1887-95
pubmed: 21471008
J Neurosci. 2011 Nov 23;31(47):17123-33
pubmed: 22114281
Epilepsia. 2012 Jun;53 Suppl 1:116-24
pubmed: 22612816
Am J Hum Genet. 2013 Aug 8;93(2):368-83
pubmed: 23871722
Development. 2014 Feb;141(3):650-60
pubmed: 24449841
Am J Med Genet A. 2014 Apr;164A(4):918-23
pubmed: 24458433
Nat Neurosci. 2014 Apr;17(4):522-32
pubmed: 24562000
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
J Cell Biochem. 2015 Dec;116(12):2980-91
pubmed: 26095893
PLoS Comput Biol. 2015 Aug 14;11(8):e1004405
pubmed: 26275289
Nat Commun. 2015 Sep 03;6:8200
pubmed: 26334723
J Neurosci. 2016 Jun 15;36(24):6431-44
pubmed: 27307232
Meta Gene. 2016 Jul 07;9:185-90
pubmed: 27617217
EMBO Rep. 2018 Oct;19(10):
pubmed: 30232163
Neurology. 1974 Mar;24(3):203-10
pubmed: 4130661
Brain Res. 1972 Sep 29;44(2):625-9
pubmed: 4263073
Science. 1974 Dec 20;186(4169):1126-8
pubmed: 4469701
J Neurosci. 1998 Oct 15;18(20):8356-68
pubmed: 9763479

Auteurs

Bhavin S Shah (BS)

Department of Cellular & Physiological Sciences & the Brain Research Centre, University of British Columbia, 2350 Health Sciences Mall, Vancouver, B.C., V6T-1Z3, Canada.

Jordan J Shimell (JJ)

Department of Cellular & Physiological Sciences & the Brain Research Centre, University of British Columbia, 2350 Health Sciences Mall, Vancouver, B.C., V6T-1Z3, Canada.

Shernaz X Bamji (SX)

Department of Cellular & Physiological Sciences & the Brain Research Centre, University of British Columbia, 2350 Health Sciences Mall, Vancouver, B.C., V6T-1Z3, Canada shernaz.bamji@ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH